An eight-year follow-up study of Home Invasive Mechanical Ventilation in Finland.
Humans
Finland
/ epidemiology
Male
Female
Aged
Middle Aged
Follow-Up Studies
Respiration, Artificial
/ statistics & numerical data
Respiratory Insufficiency
/ therapy
Home Care Services
/ statistics & numerical data
Tracheostomy
/ statistics & numerical data
Aged, 80 and over
Registries
Adult
Survival Rate
Chronic respiratory failure
Home invasive mechanical ventilation
Home mechanical ventilation
Non-invasive ventilation
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
19 Sep 2024
19 Sep 2024
Historique:
received:
29
12
2023
accepted:
02
09
2024
medline:
20
9
2024
pubmed:
20
9
2024
entrez:
19
9
2024
Statut:
epublish
Résumé
Studies on long-term invasive mechanical ventilation (IMV) via tracheostomy in chronic respiratory insufficiency are limited. The aim of this study was to clarify the use of HIMV (home invasive mechanical ventilation) within the Finnish population and to analyze the characteristics and survival rate of HIMV patients from 2015 to 2022. Data on HIMV patients was collected annually from all Finnish Hospital District patient registries between January 1, 2015, and December 31, 2022. Data included basic demographic data of the patients, underlying diagnosis, time from diagnosis to HIMV initiation, treatment duration, and mortality. This study included 179 patients. In 2015, there were 107 HIMV patients, and as of December 31, 2022, there were 95 patients. During the eight-year follow-up period, 84 patients (46.9%) died and there were 67 new patients between 2015 and2022. The prevalence of HIMV treatment in Finland was 2.4/100,000 on January 1,2015, and 1.8/ 100 000 on December 31, 2022. The average number of years living with HIMV for deceased patients at death was 10.1 ± 10.5 years largely depending on the underlying diagnosis. Of all the HIMV treatments, 32% were elective. HIMV is a rare treatment in Finland, and based on our 8-year follow-up, prevalence of HIMV is diminishing. Given the high demands, and significant costs associated with HIMV, it is essential to prepare for long treatment, when planning HIMV. It is also advisable to prolong non-invasive ventilation (NIV) treatments for as long as possible.
Sections du résumé
BACKGROUND
BACKGROUND
Studies on long-term invasive mechanical ventilation (IMV) via tracheostomy in chronic respiratory insufficiency are limited. The aim of this study was to clarify the use of HIMV (home invasive mechanical ventilation) within the Finnish population and to analyze the characteristics and survival rate of HIMV patients from 2015 to 2022.
METHODS
METHODS
Data on HIMV patients was collected annually from all Finnish Hospital District patient registries between January 1, 2015, and December 31, 2022. Data included basic demographic data of the patients, underlying diagnosis, time from diagnosis to HIMV initiation, treatment duration, and mortality.
RESULTS
RESULTS
This study included 179 patients. In 2015, there were 107 HIMV patients, and as of December 31, 2022, there were 95 patients. During the eight-year follow-up period, 84 patients (46.9%) died and there were 67 new patients between 2015 and2022. The prevalence of HIMV treatment in Finland was 2.4/100,000 on January 1,2015, and 1.8/ 100 000 on December 31, 2022. The average number of years living with HIMV for deceased patients at death was 10.1 ± 10.5 years largely depending on the underlying diagnosis. Of all the HIMV treatments, 32% were elective.
CONCLUSIONS
CONCLUSIONS
HIMV is a rare treatment in Finland, and based on our 8-year follow-up, prevalence of HIMV is diminishing. Given the high demands, and significant costs associated with HIMV, it is essential to prepare for long treatment, when planning HIMV. It is also advisable to prolong non-invasive ventilation (NIV) treatments for as long as possible.
Identifiants
pubmed: 39300366
doi: 10.1186/s12890-024-03263-8
pii: 10.1186/s12890-024-03263-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
463Informations de copyright
© 2024. The Author(s).
Références
Toussaint M, Wijkstra PJ, Mckim D, Benditt J, Winck JC, Nasiłowski J. Building a home ventilation programme: population, equipment, delivery and cost. Thorax. 2022;0:1–9.
Geiseler J, Karg O, Börger S, Becker K, Zimolong A. Invasive home mechanical ventilation, mainly focused on neuromuscular disorders. GMS Health Technol Assess. 2010;6:Doc08.
pubmed: 21289881
pmcid: 3010883
Decree of social. And healthcare customer fees 9.10.1992/912. (legislation in Finnish). www.finlex.fi. Accessed 24 Sep 2019.
Kotanen P, Kreivi H-R, Vainionpää A, Laaksovirta H, Brander P, Siirala W. Home invasive mechanical ventilation in Finland in 2015–2019. ERJ Open Res. 2020;6:00223–2020.
doi: 10.1183/23120541.00223-2020
pubmed: 33263031
pmcid: 7682663
Valko L, Baglyas S, Gal J, Lorx A. National survey current prevalence and characteristics of home mechanical ventilation in Hungary. BMC Pulm Med. 2018;18.
Tollefsen E, Gulsvik A, Bakke P, Fondenes O. Prevalens Av hjemmerespiratorbehandling i Norge. Tidsskr nor Laegeforen. 2009;129:2094–7.
doi: 10.4045/tidsskr.08.0716
pubmed: 19855446
Czajkowska-Malinowska M, Bartolik K, Nasiłowski J, Kania A. Development of Home Mechanical Ventilation in Poland in 2009–2019 based on the data of the National Health Fund. J Clin Med. 2022;11.
Rose L, McKim DA, Katz SL, Leasa D, Nonoyama M, Pedersen C, et al. Home mechanical ventilation in Canada: a national survey. Respir Care. 2015;60:695–704.
doi: 10.4187/respcare.03609
pubmed: 25587173
Tagami M, Kimura F, Nakajima H, Ishida S, Fujiwara S, Doi Y, et al. Tracheostomy and invasive ventilation in Japanese ALS patients: decision-making and survival analysis: 1990–2010. J Neurol Sci. 2014;344:158–64.
doi: 10.1016/j.jns.2014.06.047
pubmed: 25017882
Jun KY, Park J, Oh K-W, Kim EM, Bae JS, Kim I, et al. Epidemiology of ALS in Korea using nationwide big data. J Neurol Neurosurg Psychiatry. 2019;90:395–403.
doi: 10.1136/jnnp-2018-318974
pubmed: 30409890
Chiò A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G, et al. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy. J Neurol Neurosurg Psychiatry. 2010;81:1141–3.
doi: 10.1136/jnnp.2009.175984
pubmed: 20660920
Spittel S, Maier A, Kettemann D, Walter B, Koch B, Krause K, et al. Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: utilization and survival rates in a cohort study over 12 years in Germany. Eur J Neurol. 2021;28:1160–71.
doi: 10.1111/ene.14647
pubmed: 33210770
Tollefsen E, Midgren B, Bakke P, Fondenes O. Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation. Eur J Neurol. 2010;17:1352–7.
doi: 10.1111/j.1468-1331.2010.03036.x
pubmed: 20443984
Hanhisuanto M, Solje E, Jokela M, Sipilä JOT. Amyotrophic lateral sclerosis (ALS) in southwestern and eastern Finland. Neuroepidemiology. 2023. https://doi.org/10.1159/000531238 .
doi: 10.1159/000531238
pubmed: 37399804
Johansson E, Luoto TM, Vainionpää A, Kauppila A-M, Kallinen M, Väärälä E, et al. Epidemiology of traumatic spinal cord injury in Finland. Spinal Cord. 2021;59:761–8.
doi: 10.1038/s41393-020-00575-4
pubmed: 33149235
GBD Spinal Cord Injuries Collaborators. Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Neurol. 2023;22:1026–47.
doi: 10.1016/S1474-4422(23)00287-9
Sheehan DW, Birnkrant DJ, Benditt JO, Eagle M, Finder JD, Kissel J, et al. Respiratory management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142:S62–71.
doi: 10.1542/peds.2018-0333H
pubmed: 30275250
Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2 : respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17:347–61.
doi: 10.1016/S1474-4422(18)30025-5
pubmed: 29395990
pmcid: 5889091
Cantero C, Adler D, Pasquina P, Uldry C, Egger B, Prella M, et al. Long-term noninvasive ventilation in the Geneva Lake Area: indications, prevalence, and modalities. Chest. 2020;158:279–91.
doi: 10.1016/j.chest.2020.02.064
pubmed: 32243941
Hannan LM, Dominelli GS, Chen YW, Darlene Reid W, Road J. Systematic review of non-invasive positive pressure ventilation for chronic respiratory failure. Respir Med. 2014;108:229–43.
doi: 10.1016/j.rmed.2013.11.010
pubmed: 24315469
Radunovic A, Annane D, Mk R, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis / motor neuron disease (Review). Cochrane Database of Systematic Reviews. 2017. https://doi.org/10.1002/14651858.CD004427.pub4 http://www.cochranelibrary.com
Soudon P, Steens M, Toussaint M. A comparison of invasive versus noninvasive full-time mechanical ventilation in Duchenne muscular dystrophy. Chron Respir Dis. 2008;5(2):87–93. https://doi.org/10.1177/1479972308088715 . PMID: 18539722.
Bach JR. A comparison of Long-Term Ventilatory Support Alternatives from the perspective of the patient and care giver. Chest. 1993;104:1702–6.
doi: 10.1378/chest.104.6.1702
pubmed: 8252946
Vianello A, Arcaro G, Palmieri A, Ermani M, Braccioni F, Gallan F, et al. Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care. 2011;26:e3297–32914.
doi: 10.1016/j.jcrc.2010.06.003
Kaub-Wittemer D, von Steinbuchel N, Wasner M, Laier-Groeneveld G, Domenico Borasio G. Quality of life and Psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage. 2003;26.
Rousseau M-C, Pietra S, Blaya J, Catala A. Quality of life of ALS and LIS patients with and without invasive mechanical ventilation. J Neurol. 2011;258:1801–4.
doi: 10.1007/s00415-011-6018-9
pubmed: 21461685
Peseschkian T, Cordts I, Günther R, Stolte B, Zeller D, Schröter C et al. A Nation-Wide, multi-center study on the quality of life ofALS patients in Germany. Brain Sci. 2021;11.
Heritier Barras A-C, Adler D, Iancu Ferfoglia R, Ricou B, Gasche Y, Leuchter I, et al. Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group. Swiss Med Wkly. 2013;143:w13830.
pubmed: 23925784
Luo F, Annane D, Orlikowski D, He L, Yang M, Zhou M et al. Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders. Cochrane Database of Systematic Reviews. 2017;2017.
Windisch W, Simon K. German National Guideline for Treating Chronic Respiratory Failure with invasive and non-invasive ventilation – revised Edition 2017: part 2. Respi. 2018;96:171–203.
doi: 10.1159/000488667
Reito A, Sanmark E, Tuovinen T, Seppälä TT, Kuitunen I, Ponkilainen V et al. Toisiolaki – lääketieteellisen tutkimuksen mahdollistaja vai tukahduttaja? Suomen Lääkärilehti. 2022;77.
Laaksovirta H, Launes J, Jansson L, Traynor BJ, Kaivola K, Tienari PJ. ALS in Finland: Major Genetic variants and clinical characteristics of patients with and without the C9orf72 hexanucleotide repeat expansion. Neurol Genet. 2022;8:e665.
doi: 10.1212/NXG.0000000000000665
pubmed: 35295181
pmcid: 8922337